Sylvester Comprehensive Cancer Center Kendall is a clinical research site located in Miami, Florida, United States 33176.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Sylvester Comprehensive Cancer Center Kendall has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: HER2-positive Breast Cancer, Breast Neoplasms, BRCA 1 Gene Mutation.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sylvester Comprehensive Cancer Center Kendall has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sylvester Comprehensive Cancer Center Kendall has 3 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Breast Neoplasms, BRCA 1 Gene Mutation.
Sylvester Comprehensive Cancer Center Kendall has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.